This is supported by a yet unpublished study from Weill Cornell Medical Center in which all children diagnosed with PV demonstrated a JAK2 mutation, as was presented at the virtual EAHP 2020 meeting by Dr. Kucine. The gene discussed is JAK2; the disease is acquired polycythemia vera.